Shares of medical devices company AngioDynamics, Inc. (ANGO) are rising more than 10% Thursday morning on better-than-expected second-quarter results.
The company reported a net loss of $4.3 million, or $0.11 per share in the second quarter compared with net loss of $2.7 million, or $0.07 per share, a year ago.
On an adjusted basis, earnings of $0.01 per share in the quarter beat the average estimate of analysts polled by Thomson Reuters for a loss of $0.02 per share.
Net sales for the second quarter increased 4% year-over-year to $72.8 million. The consensus estimate was for $67.35 million.
"In the second half of the year, we expect ongoing COVID-related headwinds as well as typical third-quarter seasonality, which is contemplated in our full-year guidance. We are excited about the planned launch of our multi-purpose mechanical aspiration thrombectomy device in calendar 2021," said Jim Clemmer, President and Chief Executive Officer of AngioDynamics, Inc.
ANGO, currently at $17.94, touched a new high of $19.52 this morning.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.